Development and evaluation of the Acromegaly Symptom Diary

BACKGROUND: Patient-reported outcome (PRO) measures are important to consider when evaluating treatments, yet there are no PRO measures for patients with acromegaly that have been developed in accordance with US Food and Drug Administration guidance. Acromegaly is a rare, chronic condition caused by...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Susan, Bender, Randall H., Krasner, Alan, Marmon, Tonya, Monahan, Michael, Nelson, Lauren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931976/
https://www.ncbi.nlm.nih.gov/pubmed/36792844
http://dx.doi.org/10.1186/s41687-023-00541-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931976/
https://www.ncbi.nlm.nih.gov/pubmed/36792844
http://dx.doi.org/10.1186/s41687-023-00541-7

Ejemplares similares